To prevent the negative effects of ROS, cells have developed DNA repair mechanisms designed to specifically combat endogenous DNA modifications.
Whether they all lead to DNA modifications will be discussed in this section.
The principles described in this protocol can be applied to other plant species to generate stably inherited DNA modifications.
This review focuses on mechanisms of resistance and sensitivity of tumors to conventional cisplatin associated with DNA modifications.
This is controlled by epigenetic information, including DNA modifications, histone modifications, histone variants, non-coding RNAs, and chromatin architectures.
Recent advances in genomics and biochemistry have considerably elucidated the functions and provenance of these DNA modifications.
Covalent histone or DNA modifications, histone variants, ATP-dependent chromatin remodeling, and non-coding RNA are major mechanisms underlying epigenetic regulation.
A limited number of studies have been conducted to investigate DNA modifications at BDNF in BD, and most were done on postmortem brain tissue.
Zinc‐finger proteins most likely also influence epigenetic regulatory systems, such as the complex set of chemical histone and DNA modifications, which control chromatin compaction and nuclear organization.
Two alternative approaches, RecA-dependent engineering and ET recombination, allow a wide variety of DNA modifications, including some which are virtually impossible by conventional methods.
Different aspects of learning, memory, and cognition are regulated by epigenetic mechanisms such as covalent DNA modifications and histone post-translational modifications.
